AlphaCentric Advisors LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2021$612,000
-42.0%
32,000
-3.0%
0.16%
-45.6%
Q2 2021$1,055,000
-6.7%
33,000
-12.0%
0.29%
-24.7%
Q1 2021$1,131,000
+184.2%
37,500
+307.6%
0.38%
+129.5%
Q4 2020$398,000
+4322.2%
9,200
+6033.3%
0.17%
+3220.0%
Q2 2020$9,0001500.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,335,528$40,104,0004.92%
qPULA Trading Management LP 14,344$91,0000.80%
Frazier Life Sciences Management, L.P. 1,440,757$9,120,0000.70%
Ikarian Capital, LLC 462,628$2,928,0000.58%
Birchview Capital, LP 98,000$620,0000.44%
HealthCor Management, L.P. 455,000$2,880,0000.36%
Financial Advocates Investment Management 45,071$3,538,0000.29%
PDT Partners, LLC 262,767$1,663,0000.25%
Monaco Asset Management SAM 80,000$506,0000.19%
Summit X, LLC 103,424$651,0000.19%
View complete list of BLUEBIRD BIO INC shareholders